Christopher Zacca, President & CEO of Sagicor Group Jamaica Limited (SGJ or the Group) has released the following report to shareholders on the Group performance report for the year ended December 2022.
Overview
Sagicor Group Jamaica achieved net profit attributable to stockholders of $16.38 billion for the year ended December 31, 2022, a 6% reduction over the prior year but a creditable performance in a difficult year.
The Individual Life insurance segment continues to lead the Group’s profit generation, accounting for $8.74 billion in reported net profit.
The Employee Benefits and the Commercial Banking segments were also major contributors, with $4.05 billion and $3.29 billion, respectively.
The Group ended the year with earnings per share of $4.19 (December 2021: $4.46). The 2022 year-end saw the stock price closing at $59.42, an increase over prior year (December 2021: $58.25). The Group’s market capitalization ended the year at $232.07 billion, the largest of any company on the Jamaica Stock Exchange.
2022 was an extremely challenging year characterised by volatility in local and international financial markets emanating from geopolitical tensions, rising inflation, tightening of monetary policies and supply chain disruptions. Notwithstanding these challenges, Sagicor Group Jamaica continues to strategically position itself for growth by optimising our operations and transforming our business processes. In the final quarter of 2022, the Group announced a series of management changes to implement these plans. During the year the Group also entered the Cambio and Remittance market through the acquisition of Alliance Financial Services Limited and disposed of its shareholdings in Sagicor Real Estate X Fund.
The Group declared dividends totalling $1.60 per share (December 2021: $1.11 per share) during the year as part of our commitment to providing a return on capital to our shareholders, in spite of the challenging environment.
Financial Performance
Total revenue for 2022 for the Group was $97.10 billion, a 5.3% decline year over year. The Group recognized fair value losses of $3.31 billion (December 2021: $8.97 billion in gains); a result of depressed market prices for fixed income and equity securities. Sagicor’s main revenue streams were net premium revenue, net investment income and fee income. Net premium revenue improved over prior year by 7.1% to contribute $56.55 billion, a result of strong new business and policy retention. Net investment income grew by 10.7% over prior year amounting to $21.30 billion, emanating from growth in the loan portfolio and commercial banking activities. Fees and other income recorded improved results over prior year by 6.4% to close the year at $18.51 billion. This was driven mainly by income from cambio and remittance services as well as an increase in commercial banking fee income.
Total benefits and expenses for the Group decreased year over year by 3.1%, ending at a total of $75.87 billion. An upward movement in prevailing market interest rates resulted in a favourable net movement in actuarial liabilities of $8.12 billion. This was partially offset by net insurance benefits incurred and administrative expenses increasing by $2.08 billion and $3.72 billion, respectively year over year.
The Group’s statement of financial position was impacted by the sale of Sagicor Real Estate X Fund and the softening of asset prices. Total Assets and Shareholders Equity ended at $519.18 billion and $113.87 billion, respectively. The Group’s Funds under Management of $456.89 billion grew nominally year on year, contributing to the Total assets under Management of $976.07 billion, an increase over prior year (December 2021: $956.30 billion). Sagicor Group’s annualized return on equity was 14% (down from 16% in the corresponding period in 2021).
Individual Insurance
The Individual Life segment ended the period with $8.74 billion in net profit, a 2.4% decline over prior year. Net premium income grew year over year by $2.16 billion across Jamaica and the Cayman Islands, as a result of new business sales growth and policy retention. In the current year, actuarial liabilities were primarily impacted by changes to discount rates, a result of the prevailing market conditions. The prior year period included adjustments to the morbidity and lapse experience.
Employee Benefits
The Employee Benefits segment produced profits of $4.05 billion, 10.5% above prior year. Net group health premium income of $12.32 billion increased by 13.2% over the prior year, due to new business written during the period, particularly the acquisition of a large client in the Group Health portfolio. Net insurance benefits incurred increased by $1.77 billion, as medical inflation continued to trend upward, however, this was partially offset by a reduction in actuarial liabilities for the period.
Commercial Banking
The Commercial Banking segment produced a net profit of $3.29 billion, 1% higher than the prior year. The segment was aided by a 10.5% increase in total revenues, primarily due to increases in banking activities through credit card and point of sale transactions.
Additionally, a 17% growth in the segment’s loans portfolio translated to 14% or $1.52 billion increase in interest income.
Total assets of $191.8 billion grew 9.1% over December 2021. This growth was driven by a $15.47 billion increase in loan assets which ended the period at $108.49 billion. Customer deposits increased by $12.5 billion against the prior year end to total $148.9 billion as at December 2022.
Investment Banking
The Investment Banking segment’s net profit outturn was $1.20 billion, a decline of 64.2% against prior year. The prevailing macroeconomic conditions have caused a significant reduction in business transactions, adversely affecting performance.
Notwithstanding, the segment benefitted from our recently formed Cayman subsidiary, which grew its interest earnings asset base by 95% and positioned itself to benefit from higher yielding securities within the market.
Liquidity And Solvency
Cash and Cash Equivalents at the end of December 2022 were $42.94 billion, down from $51.88 billion as at December 2021. Regulatory capital requirements continue to be exceeded across all operating entities.
Outlook
As we come to the close of an undoubtedly challenging year, our outlook for 2023 remains conservative as many of the constraining factors to economic growth remain in place, namely inflation, the war in Ukraine and the lagging effect of high interest rates, causing the World Bank to issue a downward revision in global economic growth from 3% to 1.7%. We expect a continued slowing of growth amongst our key trading partners, including the United States and Britain, as consumer spending and market activity responds to the extended period of high interest rates. Domestically, we anticipate the Bank of Jamaica will remain focused on taming inflation, but indications are
that its recent market actions have been effective given the downward trajectory of this key measure.
The Group is cognizant of and well prepared for the potential impact of International Financial Reporting Standard (“IFRS”) 17. The standard which becomes effective January 1, 2023, replacing IFRS 4, is anticipated to materially change the recognition and measurement requirements for our insurance business segments, as well as the presentation and disclosures in the Group’s Consolidated Financial Statements.
For more information CLICK HERE